220352-39-6,
(1R,2S)-2-(3,4-Difluorophenyl)cyclopropanamine (2R,3R)-2,3-Dihydroxysuccinate,
(1R,2S)-2-(3,4-Difluorophenyl)cyclopropanamine (2R,3R)-2,3-dihydroxybutanedioate,
(1R,2S)-2-(3,4-Difluorophenyl)cyclopropanamine-(2R,3R)-2,3-dihydroxysuccinate,
Cyclopropanamine,2-(3,4-difluorophenyl)-(1R,2S)-(2R,3R)-2,3-dihydroxybutanedioate,
AK102386,
SCHEMBL1509199,
C13H15F2NO6,
CTK8B9185,
DTXSID40680608,
KS-00000Q8M,
1163AB,
ANW-62174,
CD0021,
MFCD22374088,
AKOS016004944,
ACN-028498,
DS-3824,
EX-7183,
AN-16970,
AX8233925,
TC-150919,
ST24033564,
(1R,2S)-2-(3,4-difluorophenyl)cyclopropanamine L-Tartaric acid,
(1R,2S)-2-(3,4-difluorophenyl)cyclopropan-1-amine; (2R,3R)-2,3-dihydroxybutanedioic acid,
(1R,2S)-2-(3,4-difluorophenyl)cyclopropanamine; (2R,3R)-2,3-dihydroxybutanedioic acid,
(2R,3R)-2,3-Dihydroxybutanedioic acid--(1R,2S)-2-(3,4-difluorophenyl)cyclopropan-1-amine (1/1),
Cyclopropanamine, 2-(3,4-difluorophenyl)-, (1R,2S)-, (2R,3R)-2,3-dihydroxybutanedioate (1:1),
FXPRRXBPZROCLZ-ABXGAMCJSA-N,
(1R,2S)-2-(3,4-Difluorophenyl)cyclopropanamine(2R,3R)-2,3-Dihydroxysuccinate,